Condition 1: Vaginal dryness and menopausal symptoms in endometriosis patients related to treatments used in endometriosis. Condition 2: Vaginal dryness and menopausal symptoms in endometriosis patients related to treatments used in endometriosis. Endometriosis Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Intervention group: This group consists of 25 endometriosis patients with symptoms of vaginal dryness who will use the probiotic LactoVage vaginally for 14 days, one capsule daily. Lac
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients undergoing endometriosis treatment who suffer from the side effects of medications, including vaginal dryness. Patients who, according to the gynecologist's diagnosis, do not have an indication to receive conjugated estrogens. Patients with mild symptoms of vaginal dryness
Exclusion criteria
Exclusion criteria: Patients with severe symptoms of vaginal dryness that require conjugated estrogen. Patients who, according to the diagnosis of a gynecologist, have indications for surgery. Patients who suffer from other menstrual disorders in addition to endometriosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal dryness. Timepoint: 14 days after taking Lactovag. Method of measurement: Clinical examination by a gynecologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElnaz Shaseb
Tabriz University of Medical Sciences
Outcome results
None listed